C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2001
11/29/2001	WO2001058935A3 FACTOR VII OR VIIa-LIKE MOLECULES
11/29/2001	WO2001044458A3 Bovine immunodeficiency virus (biv) based vectors
11/29/2001	WO2001044280A3 Methods and compositions for the manufacture of replication incompetent adenovirus
11/29/2001	WO2001043869A3 Cell arrays and the uses thereof
11/29/2001	WO2001042471A8 Polypeptides and polynucleotides encoding same
11/29/2001	WO2001040491A3 Udp-glucose:aglycon-glucosyltransferase
11/29/2001	WO2001040309A3 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use
11/29/2001	WO2001040257A3 Modified il-12 subunits and nucleic acids encoding them
11/29/2001	WO2001038566A3 Screening method for candidate drugs
11/29/2001	WO2001031007A3 Nucleic acid molecules derived from rat brain and programmed cell death models
11/29/2001	WO2001030980A3 Methods and compositions for enhancing developmental potential of oocytes and zygotes
11/29/2001	WO2001029234A3 Self-cleaving rna sequences and their use for the control of protein synthesis
11/29/2001	WO2001027304A3 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna
11/29/2001	WO2001025433A3 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization
11/29/2001	WO2001023590A3 22196, a novel human aminopeptidase
11/29/2001	WO2001016318A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/29/2001	WO2001000846A3 Linoleate isomerase
11/29/2001	WO2000075350A3 Nucleic acid sequences encoding proteins involved in fatty acid beta-oxidation and methods of use
11/29/2001	WO2000073469A3 Protein kinases
11/29/2001	WO2000040722A3 Insulin-synthesis genes
11/29/2001	WO1999049807A3 A device and method for performing a biological modification of a fluid
11/29/2001	US20010047090 VANILREP1 polynucleotides and VANILREP1 polypeptides
11/29/2001	US20010047083 Produced by hybridoma cell line ATCC No. HB12003 and progeny thereof; used in detection or treatment of carcinoembryonic antigen associated tumors
11/29/2001	US20010047080 Inhibits hiv infection of cells
11/29/2001	US20010046965 Making them safer for the large-scale production of adenovirus stock for use in human gene therapy trials.
11/29/2001	US20010046959 Method of treating cancer with anti-neurotrophin agents
11/29/2001	US20010046707 Enhancing the competence of a cell through production of a library of recombinant genes
11/29/2001	US20010046704 For use in areas such as screening, production, gentic analysis, cloning, cell therapy products, etc.
11/29/2001	US20010046694 1-deoxy-D-xylulose-5-phosphate reductoisomerases, and methods of use
11/29/2001	US20010046692 Derived from Pseudomonas jessenii
11/29/2001	US20010046662 Method of inactivating pathogens in a red blood cell-containing composition
11/29/2001	US20010046490 Cell surface molecule-induced macrophage activation
11/29/2001	US20010046489 Stem cells of the islets of langerhans and their use in treating diabetes mellitus
11/29/2001	US20010046488 Compositions and methods for delivery of an organized tissue to an organism
11/29/2001	DE10024384A1 Herstellung von dendritischen Zellen aus Rückenmarkstammzellen Preparation of dendritic cells from spinal cord stem cells
11/29/2001	DE10024383A1 Mit toxischen Substanzen beladene dendritische Zellen With toxic substances loaded dendritic cells
11/29/2001	CA2808215A1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
11/29/2001	CA2429199A1 Drug metabolizing enzymes
11/29/2001	CA2410520A1 Mutated eukariotic translation initiation factor 2 alpha kinase 3, eif2ak3, in patients with neonatal insulin-dependent diabetes and multiple epiphyseal dysplasia (wolcott-rallison syndrome)
11/29/2001	CA2410317A1 Methods for assaying gene imprinting and methylated cpg islands
11/29/2001	CA2410101A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/29/2001	CA2410096A1 Card domain containing polypeptides, encoding nucleic acids, and methods of use
11/29/2001	CA2410094A1 Compositions and methods for modulating tumor specific expression
11/29/2001	CA2410083A1 Mammalian receptor proteins; related reagents and methods
11/29/2001	CA2410082A1 Dnax toll-like receptor 7 (dtlr7) protein, related reagents and methods
11/29/2001	CA2410081A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/29/2001	CA2409978A1 Methods and means for enhancing skin transplantation using gene delivery vehicles having tropism for primary fibroblasts, as well as other uses thereof
11/29/2001	CA2409873A1 Hcv variants
11/29/2001	CA2409299A1 Compositions and methods for the therapy and diagnosis of breast cancer
11/29/2001	CA2408739A1 Novel proteins and nucleic acids encoding same, diagnostic and therapeutic uses
11/29/2001	CA2408387A1 A ligand for enhancing oral and cns delivery of biological agents
11/29/2001	CA2408315A1 Aminoacyl trna synthetases
11/29/2001	CA2408302A1 Long wavelength engineered fluorescent proteins
11/29/2001	CA2408141A1 Neurotransmitter transporters
11/29/2001	CA2408140A1 G-protein coupled receptors
11/29/2001	CA2408022A1 Pt32 sperm protein, sperm c-yes, oocyte cytoplasmic c-yes, and uses thereof
11/29/2001	CA2407872A1 Receptor-based interaction trap
11/29/2001	CA2407570A1 Compositions and methods for delivery of a molecule into a cell
11/28/2001	EP1158050A1 Human cysteinyl leukotriene receptor (CysLT2)
11/28/2001	EP1158045A1 Culture conditions allowing to modulate the expression of CYP3A4 in CaCo2 cells
11/28/2001	EP1158044A1 Method for inducing differentiation into adipocytes, compound regulating differentiation into adipocytes and method for screening the same
11/28/2001	EP1158004A2 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof
11/28/2001	EP1158003A1 Antibodies capable to selectively detect prion PrP Sc isoforms
11/28/2001	EP1158002A1 Human G-protein coupled receptor
11/28/2001	EP1157999A1 Methods and means for enhancing skin transplantation using gene delivery vehicles having tropism for primary fibroblasts, as well as other uses thereof
11/28/2001	EP1157126A1 Method for cloning signal transduction intermediates
11/28/2001	EP1157123A1 Stable recombinant influenza viruses free of helper viruses
11/28/2001	EP1157119A1 Method of modulating metabolite biosynthesis in recombinant cells
11/28/2001	EP1157118A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
11/28/2001	EP1157115A1 Expressing gp140 fragment of primary hiv-1 isolate
11/28/2001	EP1157109A2 14273 receptor, a g-protein coupled receptor
11/28/2001	EP1157104A2 Pyk2 binding proteins
11/28/2001	EP1157103A2 Production of helper dependent adenovirus vectors based on use of endonucleases
11/28/2001	EP1157096A2 Culture medium comprising meiosis activating sterols (mas) and method for invitro fertilisation
11/28/2001	EP1157043A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions
11/28/2001	EP1157036A1 Immunomodulating glycopeptide
11/28/2001	EP1156833A1 Metastasis models using green fluorescent protein (gfp) as a marker
11/28/2001	EP1156822A1 Treatment of infertility
11/28/2001	EP1156821A1 Treatment of infertility
11/28/2001	EP1156820A1 Vascular endothelial growth factor-2
11/28/2001	EP1156819A1 Methods and compositions for modulating fertility
11/28/2001	EP1156818A2 Methods and compositions for regulating protein-protein interactions
11/28/2001	EP1023085A4 Human embryonic germ cell line and methods of use
11/28/2001	EP1012268A4 Ires sequences with high translational efficiency and expression vectors containing the sequence
11/28/2001	EP0922097A4 Single-step excision means
11/28/2001	EP0845032B1 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
11/28/2001	EP0789588A4 Method for making a medicament for treating secondary immunodeficiency
11/28/2001	EP0750672B1 Dna sequences for matrix metalloproteases, their production and use
11/28/2001	EP0682711B1 Plants resistant to infection by plrv
11/28/2001	EP0592685B1 Plant resistant to two or more viruses and preparation thereof
11/28/2001	EP0460190B2 Method for detecting malignant diseases
11/28/2001	CN1324408A Nucleic acid molecules from rice and their use for the prodn. of modified starch
11/28/2001	CN1324407A Plant-optimized polynucleotides encoding approximately 15 KDa and approximately 45 KDa pesticidal proteins
11/28/2001	CN1324405A Novel G protein-coupled receptor proteins, DNAS thereof and ligands to the same
11/28/2001	CN1324403A PRV-1 gene and the use thereof
11/28/2001	CN1324400A Method of screening for large offspring syndrome
11/28/2001	CN1324399A Method and apparatus for storages of entomopathogenic nematodes
11/28/2001	CN1324254A Dermal scaffold comprising nutralized chitosan sponge, nutralized chitosan/collagen mixed sponge
11/28/2001	CN1324251A Method of stimulating prosaposin receptor activity
11/28/2001	CN1324242A Novel NEUROPILIN/growth factor binding and use thereof

1 ... 1381 1382 1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 ... 1827